Other Issues

The Consumer Healthcare Products Association (CHPA) issued the following statement today from Scott Melville, president and CEO, regarding the nomination of Robert Califf, M.D. as the next U.S. Food and Drug Administration (FDA) commissioner.

This week, the Senate Judiciary Committee held a hearing to look into legislative solutions to protect consumers who purchase goods on online platforms, namely the INFORM Consumers Act.

OTC programs strengthen member acquisition, retention, satisfaction, and care management strategies.

Join Wayfair’s Head of Product Development, Matt Phillips and John Troup to explore consumer engagement and how dietary supplements companies can help provide online services that build brand loyalty and keep people coming back.

CHPA was in Oklahoma City this week to formally launch the Oklahoma Loperamide Safety Campaign.  CHPA Vice President of Communications and Public Affairs, Mike Tringale, along with CHPA Vice President of State & Local Government Affairs, Carlos Gutierrez, visited the state capitol building to brief a number of stakeholders and lawmakers about CHPA’s work around loperamide safety.  

As healthcare transitions from a delivery to ‘self-owned’ care model, effective solutions that engage consumers are needed. During this episode, John Troup and Jenna Philips share the latest insights on the world of digital platforms and how they influence consumer engagement.

State and local policy issues impacting dietary supplements across the country.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

ACI and CHPA praise FDA for announcing the withdrawal of its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.